CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Frontier Health›
Library
Frontier Health

Frontier Health

Frontier Health develops Juno, an AI teammate that automates NHS administrative work to keep patient pathways moving.

Operating headquarters
London, GB🇬🇧
Founded
2024
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Library

Frontier Health - Library

frontierhealth.ai·Crawled Sep 27, 2026·

Topics

Publication type

Content origin
Row density

Careers & Hiring

1 page
  1. Careers/careers

    Join Frontier Health to develop context-aware AI that works across live healthcare workflows, existing hospital systems, and high-volume admin roles where reliability, visibility, and staff control matter every single day.

About

1 page
  1. About Us/about-us

    We're solving the global healthcare workforce crisis with AI that handles admin work. Meet the team bringing NHS experience and applied AI together.

Homepage

2 pages
  1. Homepage/

    Juno is a supportive AI teammate for healthcare administration teams, automating repetitive, high-volume work across existing systems, so staff can keep care moving.

  2. Homepage/

    Juno is a supportive AI teammate for healthcare administration teams, automating repetitive, high-volume work across existing systems, so staff can keep care moving.

Terms & Conditions

1 page
  1. Terms of Service/terms-of-service

    Read Frontier Health's Terms of Service. Learn about our AI co-workers for healthcare, user agreements, data protection compliance, and legal terms.

Coverage

5 items
  1. Frontier Health secures $16m fundingtechmarketview.com/ukhotviews/archive/2026/06/24/frontier-health-secures-16m-funding

    London-headquartered Frontier Health raises $16 million in seed funding to scale its Juno AI product across the NHS. Atomico leads the round, with firstminute capital and XYZ Venture Capital participating. Founder and CEO Rachel Finegold previously led Palantir’s NHS healthcare work across more than 40 trusts.

    Jun 2026 · TechMarketViewNews article

  2. An ex-Palantir leader raised $16M to point AI at the NHS's paperwork, not its doctorsthenextweb.com/news/frontier-health-16m-seed-atomico-nhs-admin-ai-juno

    Frontier Health, a London company founded in 2024 by former Palantir healthcare lead Rachel Finegold, raises a $16 million seed round to build JUNO, an AI agent for NHS administrative teams. Atomico leads the round, with participation from firstminute capital and XYZ Venture Capital; the financing is the company's first institutional funding.

    Jun 2026 · The Next WebNews article

  3. Atomico led a $16M seed. Here's what it saw in Frontier Health that convinced it to move earlier than usualtechfundingnews.com/frontier-health-16m-seed-atomico-juno-nhs-pilot-221-staff-days/

    Atomico leads a $16 million seed round in Frontier Health, whose AI agent JUNO is designed for NHS administrative teams. In an eight-week pilot at East Sussex Healthcare NHS Trust, JUNO saves 221 staff days and reduces median patient pathway time by 22%.

    Jun 2026 · TechFundingNewsNews article

  4. Frontier Health Raises $12.8M in Fundingfinsmes.com/2026/06/frontier-health-raises-12-8m-in-funding.html

    Frontier Health, a London-based developer of a patient pathway tracking and clinical administration coordination platform, raises $12.8 million in a seed round. Atomico leads the round, with participation from firstminute capital and XYZ Venture Capital; the financing brings the company’s total funding to $16 million.

    Jun 2026 · FinSMEsNews article